Designing scattering nanoparticles as carriers of photosensitizing agents for Photodynamic therapy

来源 :International Conference on Nanoscience & Technology,China 2 | 被引量 : 0次 | 上传用户:floraccc
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  As a well established clinical method, photodynamic therapy (PDT) is used for treatment of various disease including cancer and particularly for the treatment of superficial tumors (e.g.oesophagus, bladder, melanoma).PDT relies on the simultaneous presence of three components;light, photo-sensitizer and oxygen where cellular damage is caused by various reactive oxygen species, induced by the light-activated photosensitiser.
其他文献
Gene therapy based on small interfering RNA (siRNA) has emerged as a promising therapeutic approach for the treatment of numerous diseases such as cancer, genetic disorders and viral infections.Howeve
Hydrophobic therapeutic agents are frequently suffered from low water solubility and the presence of solubilizing agents such as organic solvents may cause severe side effects.We introduce a novel kin
Infectious disease, such as malaria, represents a major threat to global health causing millions of human lives often due to late diagnosis and inefficient treatment.Combining DNA-based nanosensors an
The manipulation of the physicochemical properties of materials has long been used to tailor devices towards a particular application.This is particularly true for applications in nanomedicine, since
Functionalization of nanostructures with different biological molecules has many applications in pharmaceutical science for efficient drug delivery, biomedical imaging, clinical diagnosis and therapy.
Magnetic resonance imaging (MRI), a commonly used diagnostic modality, has been proven to be an effective and indispensable imaging technique since its first appearance in 1973.MRI is non-invasive and
Increased spatial confinement occurs at multiple stages during tumourigenesis, for instance in primary tumour tissues, due to their overcrowding with proliferating cells or during metastasis, when can
Organometallic drugs have often occupied a difficult niche in terms of therapeutic value.Bioactive metal containing compounds can demonstrate high efficacy but can also suffer from a low bioavailabili
Development of fluorescence imaging probes with far-red/near-infrared (FR/NIR) emission is of central importance for in vivo imaging because of their abilities to achieve low biological autofluorescen
Various types of protein immunoassay are widely used for high-throughput proteomic analysis, but to date, the low sensitivity and narrow dynamic range have limited their capabilities in diagnostics an